slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 23,401-23,430
Pages 1,935
Rows per page 30
Slide function
23,401-23,430 of 58,039
17
The slide uses stacked bar charts to distinguish between programs with and without downstream participation.AbCellera | Results Presentation Deck | 23 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
18
The chart uses a stacked bar for 2020 to break down revenue sources (Royalties, Milestones, Research Fees).AbCellera | Results Presentation Deck | 23 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
19
The slide uses a grouped bar chart approach to show year-over-year growth in operating expenses, with specific callouts for non-recurring costs like LCO, OrthoMab, and IPO expenses.AbCellera | Results Presentation Deck | 23 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
20
The slide uses a waterfall-style annotation to show the delta between 2019 and 2020 for three distinct financial categories.AbCellera | Results Presentation Deck | 23 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
21
The slide uses a before-after comparison for three distinct financial metrics.AbCellera | Results Presentation Deck | 23 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
22
The chart illustrates the transition from 2019 cash balance to 2020 cash balance via operations, financing (Series A2, Convertible Debentures, IPO), and investments (Debt Repayment, Trianni Acquisition).AbCellera | Results Presentation Deck | 23 slides · AbCellera
Conference presentation Investor relations Beat · Closing Ask1 hit
07
Includes Y/Y growth percentages and margin percentages for each quarter.Advantage Solutions | Results Presentation Deck | 16 slides · Advantage Solutions
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
Includes non-GAAP financial measures; reconciliation note provided at the bottom.Advantage Solutions | Results Presentation Deck | 16 slides · Advantage Solutions
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
11
Includes a debt maturity bar chart and detailed tables for debt and equity instruments.Advantage Solutions | Results Presentation Deck | 16 slides · Advantage Solutions
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
14
This is a standard financial disclosure slide providing transparency into non-GAAP metrics.Advantage Solutions | Results Presentation Deck | 16 slides · Advantage Solutions
Conference presentation Investor relations 1 hit
15
Contains two distinct tables: one for Adjusted Net Income reconciliation and one for Total Net Debt calculation.Advantage Solutions | Results Presentation Deck | 16 slides · Advantage Solutions
Conference presentation Investor relations 1 hit
15
The slide categorizes products into current commercial, pipeline, and licensed products.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
16
The slide uses a combination of a bar chart for financial performance and a line chart for demand growth, with annotations highlighting growth rates and the COVID-19 impact.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
17
The chart uses a dual-line comparison to show the impact of the pandemic on product demand.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
18
The slide uses a combination of a bar chart for annual revenue and a line chart for monthly prescription volume to demonstrate product performance.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
19
The slide uses a combination of a summary table and a grouped bar chart to demonstrate competitive outperformance.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
22
Alkermes | Investor Day Presentation Deck | 144 slidesAlkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
23
The slide categorizes revenue sources into three segments: Current Proprietary Commercial Products, Under FDA Review, and Royalty Stream.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
62
Data cutoff March 1, 2021. PR=partial response, RP2D=Recommended Phase 2 Dose.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
67
The chart is a swimmer plot (a type of timeline/bar chart used in oncology clinical trials).Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
72
Swimmer plot showing patient outcomes over time.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
73
The table tracks individual patient outcomes (OC1-OC5) in a platinum-resistant ovarian cancer cohort.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
79
The slide highlights the efficacy of the SC 3 mg q7d regimen in expanding effector cells compared to IV administration.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
93
The slide demonstrates synergistic effects of combination therapy on immune cell infiltration.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
94
The chart demonstrates synergy between the two treatments.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
95
The slide presents two key metrics: tumor volume over time and Kaplan-Meier survival curves.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
106
The slide shows two line charts comparing tumor and blood concentration over time for two different subunits.Alkermes | Investor Day Presentation Deck | 144 slides · Alkermes
Conference presentation Investor relations 1 hit
35
Includes specific assumptions regarding share price, earnouts, and redemption scenarios.Xos | SPAC Presentation Deck | 51 slides · Xos
Pitch deck Investment bank 1 hit
42
Includes a disclaimer regarding stock-based compensation.Xos | SPAC Presentation Deck | 51 slides · Xos
Pitch deck Investment bank 1 hit
43
The slide provides a multi-year projection of financial metrics, showing the transition from negative to positive EBITDA and FCF.Xos | SPAC Presentation Deck | 51 slides · Xos
Pitch deck Investment bank 1 hit